Back

TCRAD: An End-to-End Framework for Antigen-Targeted T Cell Receptor Design

Li, C.; Guo, Y.; Guan, X.; Chen, H.; Zhang, Y.; Yang, P.; Lou, J.

2026-01-23 bioinformatics
10.64898/2026.01.21.700513 bioRxiv
Show abstract

Understanding and engineering T-cell receptor (TCR) specificity is central to personalized immunotherapy and antigen discovery. However, while antigen-conditioned TCR design approaches have begun to emerge, most frameworks still focus on scoring candidate TCR-pMHC pairs, and achieving high hit rates in designing functional, target-reactive TCRs remains a key bottleneck. Here, we present TCRAD, a deep learning pipeline that performs de novo design of TCR CDR3{beta} sequences conditioned on antigenic peptides. TCRAD comprises three modules: Sequence Generation, Sequence Filtration, and Structure Prediction. TCRAD can effectively generate antigen-specific CDR3{beta} sequences, discriminate functional binders with high accuracy, and predict bound and unbound structures with performance comparable to or exceeding state-of-art methods. Experimental validation using the 1G4/NY-ESO-1 system demonstrated that the model can design novel functional TCRs capable of surface expression, specific pMHC binding, and that 17.2% candidates (5 of 29) elicit antigen-induced activation. Together, these results establish TCRAD as a powerful framework for TCR sequence design, offering a scalable path toward rational engineering of antigen-specific TCRs for cancer immunotherapy, vaccine development, and personalized immunotherapeutics.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.